SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
-0.2%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$156M
AUM Growth
+$10.4M
(+7.2%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
8.53%
Top 10 Holdings %
Top 10 Hldgs %
70.68%
Holding
160
New
44
Increased
13
Reduced
28
Closed
37
Top Buys
| 1 |
Biogen
BIIB
|
$50.1M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$11.7M |
| 3 |
Cogent Biosciences
COGT
|
$9.38M |
| 4 |
Incyte
INCY
|
$6.82M |
| 5 |
Nektar Therapeutics
NKTR
|
$4.13M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$57.4M |
| 2 |
Esperion Therapeutics
ESPR
|
$8.92M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$5.7M |
| 4 |
MannKind Corp
MNKD
|
$2.84M |
| 5 |
AbbVie
ABBV
|
$2.67M |
Sector Composition
| 1 | Healthcare | 86.15% |
| 2 | Consumer Staples | 2.32% |
| 3 | Consumer Discretionary | 0.64% |
| 4 | Materials | 0.5% |
| 5 | Technology | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
151
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| – | – |
-5,629
| Closed | -$213K |
|
|
BNTCW
152
DELISTED
Benitec Biopharma Limited
BNTCW
| – | – |
-90,193
| Closed | -$36K |
|
|
DERM
153
DELISTED
Dermira, Inc.
DERM
| – | – |
-45,304
| Closed | -$1.26M |
|
|
AVEO
154
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| – | – |
0
| – | – |
|
|
CFRX
155
DELISTED
ContraFect Corporation
CFRX
| – | – |
-43
| Closed | -$35K |
|
156
Leap Therapeutics
LPTX
$11.8M
| – | – |
-8,935
| Closed | -$558K |
|
157
Ocugen
OCGN
$319M
| – | – |
-15,918
| Closed | -$1.96M |
|
158
iShares S&P 100 ETF
OEF
$22.1B
| – | – |
0
| – | – |
|
159
PTC Therapeutics
PTCT
$4.57B
| – | – |
0
| – | – |
|